Maria Febbraio
- Immunology top 0.2%
- Atherosclerosis and Cardiovascular Diseases 23
- Immune cells in cancer 15
- Cancer Research top 0.5%
- Cancer, Lipids, and Metabolism 20
- Biochemistry top 0.2%
- Molecular Biology top 0.5%
- Peroxisome Proliferator-Activated Receptors 63
- Biochemistry top 0.5%
-
- Adipokines, Inflammation, and Metabolic Diseases 20
-
- Cholesterol and Lipid Metabolism 18
-
- Adipose Tissue and Metabolism 14
-
- Cell Adhesion Molecules Research 12
- Co-authors
- Roy L. SilversteinDavid P. HajjarStanley L. HazenEugene A. PodrezHenry F. HoffNada A. AbumradKavita SharmaOlga V. Volpert
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (12 papers)Circulation (4 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Maria Febbraio
169 papers receiving 18.8k citations
Hit Papers
Peers
Comparison fields: 5 of 146
- Immunology 5.5k
- Cancer Research 2.5k
- Biochemistry 998
- Molecular Biology 9.2k
- Biochemistry 788
Countries citing papers authored by Maria Febbraio
This map shows the geographic impact of Maria Febbraio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Febbraio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Febbraio more than expected).
Fields of papers citing papers by Maria Febbraio
This network shows the impact of papers produced by Maria Febbraio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Febbraio. The network helps show where Maria Febbraio may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Maria Febbraio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2023 | 7 | |
| 4 | 2023 | 3 | |
| 5 | 2021 | 11 | |
| 6 | 2021 | 2 | |
| 7 | 2020 | 53 | |
| 8 | 2018 | 2 | |
| 9 | 2017 | 55 | |
| 10 | 2012 | 152 | |
| 11 | 2012 | 52 | |
| 12 | 2009 | 98 | |
| 13 | 2007 | 80 | |
| 14 | 2005 | 255 | |
| 15 | 2004 | 318 | |
| 16 | 2003 | 147 | |
| 17 | 2001 | 87 | |
| 18 | 2000 | 354 | |
| 19 | 2000 | 102 | |
| 20 | Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in micebreakdown → | 2000 | 816 |
About Maria Febbraio
Maria Febbraio is a scholar working on Immunology, Periodontics and Cancer Research, having authored 170 papers that have together received 19.0k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (63 papers), Atherosclerosis and Cardiovascular Diseases (23 papers), Adipokines, Inflammation, and Metabolic Diseases (20 papers), Cancer, Lipids, and Metabolism (20 papers), Cholesterol and Lipid Metabolism (18 papers), Immune cells in cancer (15 papers), Adipose Tissue and Metabolism (14 papers) and Cell Adhesion Molecules Research (12 papers). The work is most often cited by research in Immunology (5.5k citations), Cancer Research (2.5k citations) and Biochemistry (998 citations). Maria Febbraio has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Roy L. Silverstein, David P. Hajjar, Stanley L. Hazen, Eugene A. Podrez, Henry F. Hoff, Nada A. Abumrad, Kavita Sharma, Olga V. Volpert, Susan E. Crawford and Benilde Jiménez. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.